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Abstract
Background: Ribosomal protein S6 kinase 1(S6K1) is an evolutionary conserved kinase that is activated in response
to growth factors and viral stimuli to influence cellular growth and proliferation. This downstream effector of target
of rapamycin (TOR) signaling cascade is known to be directly activated by TOR- kinase mediated hydrophobic
motif (HM) phosphorylation at Threonine 412 (T412). Selective loss of this phosphorylation by inactivation of TOR
kinase or activation/recruitment of a phosphatase has accordingly been implicated in mediating inhibition by
rapamycin.
Findings: We present evidence that baculovirus driven expression of S6K1 in insect cells (Sf9) fails to activate the
enzyme and instead renders it modestly active representing 4-6 folds less activity than its fully active mammalian
counterpart. Contrary to the contention that viral infection activates TOR signaling pathway, we report that BVr
enzyme fails to exhibit putative TOR dependent phosphorylation at the HM and the resultant phosphorylation at
the activation loop (AL) of the enzyme, correlating with the level of activity observed. Surprisingly, the BVr enzyme
continued to exhibit sensitivity to rapamycin that remained unaffected by mutations compromised for TOR
phosphorylation (T412A) or deletions compromised for TOR binding (ΔNH 2-46/ΔCT104).
Conclusions: These data together with the ability of the BVr enzyme to resist inactivation by phosphatases
indicate that inhibition by rapamycin is not mediated by any phosphorylation event in general and TOR
dependent phosphorylation in particular.
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Findings
S6K1 is a ubiquitously expressed serine/threonine pro-
tein kinase that phosphorylates 40S ribosomal protein
S6, and coordinates cellular growth and proliferation.
Multiple independent phosphorylations have been pro-
posed to account for complete activation of the enzyme
in response to growth factor stimulation [1]. A battery
of protein kinases coordinate to accomplish the activa-
tion of the enzyme through a series of phosphorylation
events that culminate in phosphorylating Threonine 412
(T412) at HM and Threonine 252 (T252) at the AL
[2-7]. The dynamics of these critical phosphorylations,
in particular the one at the HM therefore, dictates the
activation state of the enzyme. Accordingly selective loss
of this TOR kinase dependent phosphorylation has been
implicated in mediating the inhibitory effects of rapamy-
cin, through direct inactivation of TOR kinase, or
through activation/recruitment of a phosphatase [8-11].
In addition to Insulin and other growth factor stimula-
tion, S6K1 has also been reported to get activated in
response to viral infection, such that baculovirus
mediated expression of the enzyme in insect cells acti-
vates the enzyme by phosphorylation at similar sites as
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any medium, provided the original work is properly cited.identified in the enzyme from regulated cells [12]. Since
it stands established that insect S6 kinase, behaves simi-
lar to that of its mammalian counterpart, it is conceiva-
ble that the activation state of the enzyme and its
inhibition by rapamycin would be no different than the
one established for mammalian systems [13,14]. Further-
more, since the stimulus due to viral infection can at no
point be disengaged in Sf9 cells, the state of S6K1 acti-
vation could be deemed as constitutive and therefore,
ideal to investigate the dynamics of activating phosphor-
ylations in presence of rapamycin. Herein we provide
evidence that activity or rapamycin sensitivity of Baculo-
virus recombinant enzyme (BVr) is not dependent on
any posttranslational phosphorylation events in general
and TOR- mediated phosphorylation in particular.
Baculovirus recombinant (BVr) ribosomal protein S6
kinase (S6K1), expressed in Sf9 cells described along
with other methodological details in Additional file 1
was active towards phosphorylating GST-S6 in confor-
mity with earlier findings [12]. The activity of the
recombinant enzyme was 2-3 folds less than the random
activity (without serum withdrawal or stimulation)
exhibited by the enzyme transiently expressed in HEK
293 cells (Figure 1). Since the HEK enzyme could be
activated a further 2-3 fold following stimulation, the
BVr- enzyme in effect, was 4-6 fold less active than its
mammalian counterpart. As seen in Figure 1, the BVr-
enzyme was as sensitive to inhibition by rapamycin in a
manner more or less comparable to the inhibition curve
obtained for transiently expressed enzyme in HEK 293
cells. We have consistently observed slight recalcitrance
of the enzyme to rapamycin inhibition, when the drug
treatment is carried out without serum deprivation or
after serum stimulation of the enzyme. Since serum or
amino acid deprivation does not recreate the serum
starved state in Sf9 cells, the concentration of rapamycin
required to bring about inhibition was obviously higher
than required otherwise. Furthermore the quantum of
protein expression in Sf9 system was also an important
determinant in establishing inhibitory concentration of
the drug (not shown). Accordingly 20-24 hr post infec-
tion period, with a multiplicity of infection (MOI) of ≤ 1
was chosen as optimal time point where the level of
recombinant protein was appropriate to achieve > 90%
inhibition in activity at a concentration of 50 nM rapa-
mycin. Immunoblot analysis using anti-phospho T412
and T252 antibodies easily established these phosphory-
lations in the enzyme immuno precipitated from HEK
293 cells, whose levels were seen to decrease consider-
ably in the enzyme recovered from rapamycin treated
cells (Figure 2). Surprisingly the antibodies failed to
identify any of these phosphorylations in the BVr-
enzyme in a series of experiments, even when the mem-
branes with commasie stained bands were probed. The
absence of these phosphorylations in the BVr- enzyme
though conceivable in view of its lesser activity was sur-
prising to account for its continued inhibition by rapa-
mycin in the context of substantial evidence implicating
these phosphorylations, especially T412 to mediate the
inhibitory effects of the drug [11,15]. It could however,
be argued that the presence of only a minute fraction of
phospho T412 and T252 in the BVr- enzyme might
escape detection through immuno blotting. That being
the case, the BVr- enzyme would tend to be more sen-
sitive to inactivation by phosphatase than otherwise.
Figure 3 shows that potato acid phosphatase or phos-
phatase 2A failed to bring about any significant inacti-
vation of the enzyme at concentrations that were
effective in de-phosphorylating T412 from the HEK-
293, CHO and NIH-3T3 immunoprecipitated enzyme,
thereby disregarding the argument about the possible
existence of a minor fraction of phospho T412 and
T252 in the BVr enzyme. It is pertinent to emphasize
that only a few important phosphorylation sites that
include T252, T412 and Ser394 (S394) remain critical
for activity in backdrop of the data that loss of phos-
phorylation sites in the carboxy terminal auto
Figure 1 Comparative activity and rapamycin response of BVr
and HEK S6K. Sf9 cells infected with HA-S6K1a1 virus at an M.O.I
of ≤ 1 in TNM-FH media supplemented with 5% FBS and HEK-293
cells transiently transfected with HA-S6K1 in DMEM containing 5%
FBS were grown for 24 and 48 hours respectively. Cells were
exposed to rapamycin or ethanol for 15 min at indicated
concentrations before harvest. Lysates were clarified and used for
inmunoprecipitation with a HA antibody. Immune complexes
recovered were subjected to kinase assays in presence of
32pATP
using GST-S6 or S6 peptide as a substrate. Samples were separated
on a 12% SDS-PAGE gel transferred on to a PVDF membrane for
autoradiography or immunoblotting. Peptide kinase assays were
performed by standard procedure and the activity in Cpm (Counts
per minute) normalized to 100% for comparison. The data is a
representative expression of four independent experiments.
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appreciable change in the activity of the enzyme [6].
As such the resistance of the enzyme to phosphatase
inactivation could only be explained if these sites were
either absent or not accessible for phosphatase action.
Since T412 and T252 are established post translational
events, and the kinases that phosphorylate these sites
identified [11,16,17] the contention of their inaccessi-
bility was certainly not plausible. The only other site
that assumed significance in terms of its requirements
for enzyme activity in this system, S394 believed to be
co-translational [18], understandably continued to
resist phosphatase action (Figure 3a). Interestingly sig-
nificant residual activity continues to be detected in
the enzyme expressed in CHO-IR and NIH-3T3 cells
even after the phosphorylation at T412 was more or
less completely removed by phosphatase treatment
(Figure 3b) lending credence to the observed resistance
of BVr enzyme to phosphatase inactivation. We finally
resorted to introduce phospho deficient mutations at
the HM (T412) to Alanine (T412A) and AL (T252) to
Alanine (T252A) to provide unequivocal evidence
about their potential relevance or otherwise in influen-
cing activity and or rapamycin sensitivity of the recom-
binant enzyme. Since neither mutation engendered
any dramatic effects on either property of the enzyme
(Figure 4a) it could be concluded that the activity of
the BVr enzyme was not in any way due to either of
the activating phosphorylations and neither phosphory-
lation was responsible for mediating the inhibitory
effects of rapamycin. Since the activation and rapamy-
cin sensitivity of the enzyme has also been shown to
Figure 2 Status of activating phosphorylations in HEK and
BVrS6K1. HA-S6Ka1 immuno-precipitated from HEK 293 cells or Sf9
cells treated with or without rapamycin (50nM), were subjected to
immune-complex kinase assay using GST-S6 as substrate and
separated on 12% SDS-PAGE gel for autoradiography. Alternatively
immune complexes were transferred on to a PVDF membrane for
probing with indicated antibodies. The results represent typical of
three independent observations.
Figure 3 BVr-S6K1 is resistant to phosphatase inactivation.S 6 K a1-WT immuno-precipitated with anti-HA antibodies from infected Sf9, HEK
293, CHO or NIH-3T3 cells as above. The immunoprecipitate was split into aliquots and incubated with indicated concentrations of acid
phosphatase (3a, 3b) or protein phosphatase 2A (b) for 30 min and washed with buffer containing phosphatase inhibitors or okadaic acid (5nM)
respectively, followed by excessive washing with kinase buffer and processed for S6 phosphorylation assay as above.
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through amino and carboxy terminal TOR signaling
(TOS) motifs [19-21] it was imperative to examine,
whether deletion of these motifs did indeed reproduce
effects in accordance with the prevalent interpretations
for mammalian cell system. Surprisingly the double
mutant exhibited 2-3 fold more activity and partial
resistance to rapamycin, in conformity with its
reported behavior in mammalian cells (Figure 4b).
However, the explanation attributing this mutation to
facilitate direct phosphorylation at the HM is comple-
tely redundant in view of its absence in the BVr
enzyme. It is therefore, sa f et oc o n c l u d et h a tT O R
recruitment and the resultant phosphorylation at the
HM does not mediate the inhibitory effects of rapamy-
cin. Increased activity associated with the mutant may
therefore, be simply due to steric freedom achieved by
the truncated version of the enzyme ordinarily accom-
plished by activating phosphorylations. Rapamycin may
instead potentiate a cellular event other than phos-
phorylation via binding or dissociation of a regulatory
factor that changes the conformation of the enzyme
such that it fails to engender these critical phosphory-
lations. Accordingly truncations that override such
constraints would activate the enzyme and override
rapamycin inhibition, without necessary dependence
on phosphorylations, as stands reported for other such
truncations [22].
In the absence of the activating phosphorylations and
lesser activity associated with the BVr-enzyme, it can be
concluded that the viral infection per se does not acti-
vate the enzyme but instead appears to lock it in a state
of activity comparable to a rather amplified basal (serum
starved) state of the mammalian cells, in complete dis-
agreement with the conclusion drawn by some investi-
gators [12]. The stimulus required to bring about
activating phosphorylations may therefore, be either
absent in insect cells or inactivated due to viral infec-
tion, undermining the existence of kinases responsible
to bring about both AL and HM phosphorylations
[13,23]. It is therefore, obvious to contemplate that TOR
signaling pathway that supposedly mediates both activa-
tion and rapamycin inhibition otherwise established in
the insect cell system [13,24], fails to phosphorylate and
activate the enzyme yet continues to mediate inhibition
by rapamycin. Therefore, it seems that while the process
of activation remains unaccomplished, viral infection
preserves the events responsible for mediating rapamy-
cin inhibition. In other words the activation and sensi-
tivity to rapamycin appear to be two independent
events, in complete contravention to prevalent hypoth-
eses. Baculoviral infection in a way serves to provide a
better system where the basal state, i.e. the form of the
enzyme without phosphorylations at the HM and AL, is
completely disengaged from the activation state other-
wise quite difficult to achieve in a mammalian system.
Since, it would be strange to contemplate a unique
mechanism of rapamycin action for BVr-enzyme it is
possible to contemplate the loss of activating phosphor-
ylations in mammalian cells otherwise construed as
mechanistic may in effect be only the consequence of
rapamycin inhibition. It is however, imperative to vali-
date the contention for better understanding of the
process.
Additional material
Additional file 1: The file contains detailed description of methods
used in the communication.
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Figure 4 Tor signaling input is not required for rapamycin
inhibition of BVr enzyme. Sf9 cells were infected with S6Ka1WT,
S6Ka1T412A and T252A (a) or S6Ka1WT & S6K ΔNH2-46/ΔCT104 (b)
recombinant viruses at an M.O.I ≤ 1. Cells were exposed to
rapamycin (50 nM) or vehicle, 24 h post infection for 15 min and
harvested, lysed for IPs and subjected to S6 kinase as above. The
figure is representative of three independent experiments.
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